Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome

J Sun, J Zhao, F Jiang, L Wang, Q Xiao, F Han… - Genome medicine, 2023 - Springer
Background The proteome is a major source of therapeutic targets. We conducted a
proteome-wide Mendelian randomization (MR) study to identify candidate protein markers …

High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive

J Wilczyński, E Paradowska, M Wilczyński - Biomedicines, 2024 - mdpi.com
High-grade serous ovarian cancer (HGSOC) is the most lethal tumor of the female genital
tract. Despite extensive studies and the identification of some precursor lesions like serous …

Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma

Q Wang, Q Shi, Z Wang, J Lu, J Hou - BMC medicine, 2023 - Springer
Background Multiple myeloma (MM) is a severely debilitating and fatal B-cell neoplastic
disease. The discovery of disease-associated proteins with causal genetic evidence offers a …

Predicted proteome association studies of breast, prostate, ovarian, and endometrial cancers implicate plasma protein regulation in cancer susceptibility

I Gregga, PDP Pharoah, SA Gayther… - … Biomarkers & Prevention, 2023 - AACR
Background: Predicting protein levels from genotypes for proteome-wide association studies
(PWAS) may provide insight into the mechanisms underlying cancer susceptibility. Methods …

The role of microfibrillar‐associated protein 2 in cancer

W Xu, M Wang, Y Bai, Y Chen, X Ma, Z Yang… - Frontiers in …, 2022 - frontiersin.org
Microfibrillar-associated protein 2 (MFAP2), a component of the extracellular matrix, is
important in controlling growth factor signal transduction. Recent studies have shown that …

MFAP2 aggravates tumor progression through activating FOXM1/β‐catenin‐mediated glycolysis in ovarian cancer

LQ Zhao, W Sun, P Zhang, W Gao… - … Journal of Medical …, 2022 - Wiley Online Library
Ovarian cancer is one of the most common gynecological tumors that seriously endanger
the health and quality of life of women. Microfibril‐associated protein 2 (MFAP2) has been …

Pan‐Cancer Analysis of Microfibrillar‐Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification

Z Qiu, M Xin, C Wang, Y Zhu, Q Kong… - Journal of …, 2022 - Wiley Online Library
MFAP2 has been reported to play an oncogenic role in several types of human cancers.
However, the expression profile of MFAP2 in various cancers and its impact on prognosis …

Upregulation of microfibrillar‑associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma

N Zhang, F Shao, W Jia - Oncology Letters, 2021 - spandidos-publications.com
Abnormal expression of microfibrillar‑associated protein 2 (MFAP2), a key regulator of
cellular differentiation, affects the occurrence and progression of tumors. However, the …

Integrating proteomics and explainable artificial intelligence: a comprehensive analysis of protein biomarkers for endometrial cancer diagnosis and prognosis

S Yasar, FH Yagin, R Melekoglu… - Frontiers in Molecular …, 2024 - frontiersin.org
Endometrial cancer, which is the most common gynaecological cancer in women after
breast, colorectal and lung cancer, can be diagnosed at an early stage. The first aim of this …

Causal relationships of familial hypercholesterolemia with the risk of multiple vitamin deficiencies: a Mendelian randomization study

C Zhang, G Wei, H Zhou, L Liu - Frontiers in Endocrinology, 2024 - frontiersin.org
Background The causal relationship between familial hypercholesterolemia (FH) and
various vitamin deficiencies has not yet been elucidated. Therefore, this study investigated …